# 输血设备市场

> 血液输注设备市场研究报告按产品类型（自动血液输注设备、半自动血液输注设备、手动血液输注设备）、按最终用户（医院、血库、门诊手术中心、居家护理）、按应用（外科手术、创伤病例、癌症治疗、血浆交换）、按组件（血袋、血液过滤器、输注套件）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 4.05%
- **2024:** $ 4.7 Billion
- **2025:** $ 4.89 Billion
- **2035:** $ 7.27 Billion
- **Key Players:** Terumo Corporation (JP), Fresenius Kabi AG (DE), Grifols S.A. (ES), Haemonetics Corporation (US), Baxter International Inc. (US), BloodCenter of Wisconsin (US), Macopharma (FR), Medtronic plc (IE), Lifesource Blood Services (US)

**Report ID:** MRFR/HC/35118-HCR · **Pages:** 128 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** August 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/blood-transfusion-device-market-37044

---

## Market Summary

## **Blood Transfusion Device Market Overview**

As per MRFR analysis, the Blood Transfusion Device Market Size was estimated at 4.70 (USD Billion) in 2024. The Blood Transfusion Device Market Industry is expected to grow from 4.89 (USD Billion) in 2025 to 6.99 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.05% during the forecast period (2025 - 2034).

### **Key Blood Transfusion Device Market Trends Highlighted**

The Blood Transfusion Device Market is witnessing significant market trends driven by a strong focus on improving blood safety and efficiency in transfusion processes. The increasing prevalence of chronic diseases, rising surgical procedures, and a growing aging population are propelling the demand for blood transfusion devices. Advances in technology, such as automated blood collection and testing devices, contribute to improving accuracy and reducing the risk of transfusion-related complications.

Furthermore, the expansion of healthcare infrastructure in emerging markets presents opportunities for growth as these regions seek to enhance their medical capabilities and address patient needs. Recent trends indicate a shift towards the integration of digital solutions within blood transfusion practices. 

The use of software for tracking blood products and enhancing the management of blood banks is becoming more common, allowing for better inventory management and traceability. Additionally, the trend toward single-use, disposable devices is gaining traction, driven by concerns over cross-contamination and the need for increased efficiency in healthcare settings.  The market is also experiencing a surge in research and development activities focused on creating innovative blood transfusion devices. 

Emerging technologies like microfluidics, point-of-care testing, and blood component separation are expanding the scope of transfusion practices.Continued collaboration between hospitals, blood banks, and technology providers can unlock further innovations and improve patient outcomes. By adapting to these trends and leveraging new opportunities, stakeholders in the market can enhance their offerings and address the evolving needs of healthcare systems worldwide.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Blood Transfusion Device Market Drivers**

### **Increasing Demand for Blood Transfusion Devices**

The demand for blood transfusion devices has been witnessing a significant rise, primarily driven by an increase in surgical procedures and the prevalence of various medical conditions requiring blood transfusions. As hospitals and healthcare facilities expand and modernize, there is a growing need for advanced blood transfusion technologies to enhance patient care and safety. The Blood Transfusion Device Market Industry is particularly impacted by the rise in trauma cases, surgical interventions, and the management of chronic diseases, leading to higher volumes of blood transfusions.Enhanced awareness about the significance of timely and safe blood transfusions further bolsters the market growth. 

Alongside the expanding patient population and advancements in healthcare infrastructure, there is a critical requirement for more efficient and reliable transfusion devices. The integration of cutting-edge technologies, such as automated and smart devices, is paving the way for improving the accuracy and efficiency of blood transfusion processes, thereby positively impacting the Blood Transfusion Device Market Industry.

Furthermore, given the aging population and the lower prevalence of blood donation in many regions, the necessity for advanced blood transfusion systems becomes more pronounced, driving further market growth. Market players are constantly innovating and upgrading their offerings to meet evolving regulatory standards and consumer expectations, thus ensuring a sustainable increase in the blood transfusion device market.

### **Technological Advancements in Blood Transfusion Devices**

The rapid technological advancements in the Blood Transfusion Device Market Industry are significantly contributing to market growth. Innovations such as automated blood collection systems and smart transfusion devices that enhance the efficiency and safety of blood transfusions are becoming increasingly prevalent. These advancements are improving accuracy in blood matching, reducing transfusion reactions, and streamlining the overall transfusion process.The implementation of better tracking systems and data management solutions is also transforming the way blood transfusions are conducted, ensuring better patient outcomes and increasing operational efficiency for healthcare providers.

### **Growing Awareness of Blood Donation**

As awareness surrounding the importance of blood donation increases, there is a corresponding rise in the availability of safe blood and blood products. This growing consciousness boosts the demand for blood transfusion devices, as a higher volume of blood donation necessitates efficient and effective transfusion technology. Blood donation campaigns and initiatives led by various organizations are helping to educate the public about the significance of blood donation, thus contributing positively to the supply chain and enhancing the overall performance of the Blood Transfusion Device Market Industry.

## **Blood Transfusion Device Market Segment Insights**

### **Blood Transfusion Device Market Product Type Insights**

The Blood Transfusion Device Market is experiencing steady growth, largely driven by advancements in medical technology and increasing demand for safe blood transfusion processes. In 2023, the overall market valuation reached 6.99 USD Billion, with expectations to grow significantly by 2034. The market classification based on Product Type includes Automatic Blood Transfusion Devices, Semi-Automatic Blood Transfusion Devices, and Manual Blood Transfusion Devices, each contributing uniquely to the overall landscape. 

Automatic Blood Transfusion Devices held a strong position with a valuation of 1.5 USD Billion in 2023, indicating their effectiveness in enhancing efficiency and reducing human error during transfusion procedures, a feature increasingly favored in modern healthcare settings. This sub-segment is expected to expand to 2.2 USD Billion by 2032, reflecting a growing preference for automation in medical technologies.

Semi-Automatic Blood Transfusion Devices also play a vital role, valued at 1.3 USD Billion in 2023 and projected to reach 2.0 USD Billion by 2032. These devices serve as an interim solution for healthcare facilities that seek a balance between manual operation and full automation, proving significant due to their adaptability in various clinical environments. Furthermore, Manual Blood Transfusion Devices, valued at 1.54 USD Billion in 2023 and 6.99 USD Billion by 2034, underscore the traditional methods still in use, particularly in settings where technology integration is limited.

While this segment remains important, it exhibits a comparatively slower growth rate, as modern medical practices tend to favor devices that improve fluid administration safety and efficiency.

The Blood Transfusion Device Market segmentation reflects varied growth trajectories, with Automatic Blood Transfusion Devices dominating the segment while driving technological innovations. The consistent rise in surgical procedures and trauma cases worldwide is a significant driver of the market, necessitating the development of efficient blood management strategies. However, challenges such as the high initial costs of more advanced devices and the need for specialized training remain barriers to widespread adoption. 

Opportunities arise from expanding healthcare infrastructure, particularly in emerging markets, where the demand for improved transfusion practices is on the rise. As the landscape evolves, the ability to adapt to changing regulations and patient safety concerns will dictate the competitive dynamics within the Blood Transfusion Device Market, guiding future innovations and investments.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Blood Transfusion Device Market End User Insights   **

In 2023, the Blood Transfusion Device Market is expected to witness significant activity across various end-user segments, mainly encompassing hospitals, blood banks, ambulatory surgical centers, and home care settings. Hospitals are crucial as they account for a majority share in the demand for blood transfusion devices due to their need for large volumes of blood products for surgical procedures and emergency care. Blood banks play a significant role in the processing, storage, and distribution of blood products, ensuring a steady supply for hospitals and clinics.

Ambulatory surgical centers are becoming increasingly important as they enhance patient care by typically performing procedures that require transfusions on an outpatient basis. Finally, home care settings are gaining traction as advancements in medical technology allow for easier administration of transfusions in non-clinical environments, improving patient convenience and reducing hospital visits. Overall, the diverse applications of blood transfusion devices across these segments underline the critical nature of blood management in healthcare support systems.Various factors, such as increasing surgical procedures and rising incidences of blood disorders are driving the Blood Transfusion Device Market growth.

### **Blood Transfusion Device Market Application Insights   **

The Blood Transfusion Device Market revenue in 2023 was valued at approximately 4.34 USD billion, showcasing a steady growth trajectory that continues to gain momentum. This segment of the market is pivotal as it caters to various critical needs in healthcare, including surgical procedures, trauma cases, cancer treatment, and plasma exchange. Surgical procedures are significant due to their frequent reliance on blood transfusions to ensure patient safety and optimize outcomes. Trauma cases similarly demand rapid and effective blood management, highlighting the importance of blood transfusion devices in emergency medicine.

[Oral Cancer treatment](../../../reports/oral-cancer-treatment-market-1820) has also seen a surge in the need for blood products, with patients often requiring transfusions during complex therapies. Meanwhile, plasma exchange is crucial for treating various medical conditions, thereby establishing itself as a major component within the Blood Transfusion Device Market segmentation. Collectively, these applications underscore the essential role of blood transfusion devices in modern healthcare and signal robust market growth driven by advancing medical technologies and increasing patient care needs.The Blood Transfusion Device Market statistics indicate a broader trend towards enhancing the efficiency and safety of transfusions across these critical applications.

### **Blood Transfusion Device Market Component Insights   **

The Blood Transfusion Device Market, particularly focusing on the Component segment, demonstrates significant value and potential for growth. In 2023, the market was valued at 4.34 billion USD, reflecting the increasing demand for efficient blood management solutions. Within this segment, Blood Bags play a crucial role as they are essential for the storage and transport of blood products, significantly influencing the overall market dynamics.

Blood Filters are also vital, ensuring the safety and quality of blood transfusions by eliminating impurities, thus enhancing patient outcomes.Infusion Sets, which are used to administer blood products, hold a considerable share and are paramount in streamlining the transfusion process. 

Overall, the market growth is driven by advancements in technology, increasing incidence of hematological disorders, and a rising number of surgical procedures, while challenges such as regulatory compliance and product recalls continue to shape the landscape. The Blood Transfusion Device Market segmentation highlights the importance of these components in addressing the growing demands of healthcare providers and optimizing patient care.

### **Blood Transfusion Device Market Regional Insights   **

The Blood Transfusion Device Market is experiencing steady growth across various regions, contributing to an overall market value of 4.34 USD Billion in 2023. North America holds a majority share of this market, valued at 1.8 USD Billion, and is projected to reach 2.6 USD Billion by 2032, driven by advanced healthcare infrastructure and technological innovations.

Europe follows with a significant valuation of 1.3 USD Billion in 2023, expected to rise to 1.9 USD Billion, as the region emphasizes the safety and efficiency of transfusion practices.The APAC region, currently valued at 0.8 USD Billion, is anticipated to grow to 1.2 USD Billion, primarily due to increasing healthcare accessibility and rising patient populations. 

In contrast, South America and MEA, both valued at 0.2 USD Billion in 2023, show slower growth prospects, projected to reach 0.3 USD Billion by 2032, reflecting challenges such as limited healthcare resources. These variations in the Blood Transfusion Device Market segmentation highlight the diverse dynamics and opportunities in each region, influenced by local healthcare practices and investment in medical technology.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Blood Transfusion Device Market Key Players and Competitive Insights**

The Blood Transfusion Device Market has emerged as a critical segment within the healthcare industry, driven by the increasing demand for safe and effective blood transfusion practices worldwide. This market encompasses a range of devices, including blood collection systems, blood bags, blood filters, and infusion pumps, tailored to enhance patient outcomes and address healthcare challenges associated with blood transfusions. The market landscape is characterized by a mix of established players and emerging companies that are actively innovating and expanding their product offerings, thus intensifying the competitive environment. 

Factors such as technological advancements, regulatory changes, and varying regional demands play significant roles in shaping strategic approaches undertaken by companies. Manufacturers are focused on enhancing the efficiency and safety of transfusion devices while also targeting specific clinical needs, creating opportunities for growth.Beckton Dickinson has established a formidable presence in the Blood Transfusion Device Market, leveraging its extensive expertise and innovative capabilities. The company is recognized for its commitment to quality and safety, which is paramount in transfusion practices.

Beckton Dickinson’s strength lies in its broad product portfolio that incorporates advanced blood collection systems and equipment designed for optimal patient care. 

Its strong research and development initiatives ensure that the company remains at the forefront of technological advancements in transfusion devices. Furthermore, Beckton Dickinson benefits from a robust global distribution network, enhancing its competitiveness and ability to respond swiftly to market demands across various regions. The company’s strategic partnerships and collaborations further amplify its market presence, enabling it to deliver specialized solutions tailored to healthcare providers' needs worldwide.Medica has carved a niche for itself within the Blood Transfusion Device Market through a focused approach to product development and customer service. 

The company is recognized for its high-quality blood transfusion device that emphasize reliability and ease of use, making them a trusted choice among healthcare professionals. Medica’s strengths are showcased through its dedicated efforts in understanding customer requirements and leveraging feedback to optimize its offerings. This customer-centric strategy, combined with its commitment to maintaining rigorous quality standards, positions Medica favorably in a competitive landscape. The company also invests in research and development to innovate and improve its existing products, ensuring they meet the evolving needs of the healthcare market. 

Through targeted marketing strategies and maintaining strong relationships with healthcare institutions, Medica aims to enhance its footprint in the Blood Transfusion Device Market, thereby contributing to improved transfusion practices and patient outcomes.

### **Key Companies in the Blood Transfusion Device Market Include**

- **[Beckton Dickinson](https://www.bd-products.com/products/ivsets/products.php?mid=3&NON_DEDICATED=Yes&BLOODSET=Yes)**
- Medica
- Baxter International
- Smiths Medical
- Grifols
- Macopharma
- Fresenius Kabi
- Sangui Biotech
- Haemonetics
- Medtronic
- Lifestram
- Cerus
- Abbott
- Terumo
- R. Bard

## Blood Transfusion Device Market Industry Developments

- **Q2 2024: EryPharm announces major technological breakthrough in mass-producing cultured red blood cells to develop alternative blood transfusion sources** EryPharm, a biotech startup, announced a significant advance in the mass production of cultured red blood cells, aiming to provide alternative sources for blood transfusion and improve the quality of life for multi-transfused patients suffering from inherited or acquired red blood cell disorders.[3]

Additionally, Baxter International has introduced new devices aimed at improving blood preservation and storage, a move that reflects the growing demand in the healthcare sector. The market valuation for these companies is rising steadily, contributing to an optimistic growth outlook for the Blood Transfusion Device Market, as stakeholders are responding to the increasing global demand for safe blood transfusion services impacted by ongoing healthcare challenges.

## **Blood Transfusion Device Market Segmentation Insights**

### **Blood Transfusion Device Market Product Type Outlook**

- Automatic Blood Transfusion Devices
- Semi-Automatic Blood Transfusion Devices
- Manual Blood Transfusion Devices

### **Blood Transfusion Device Market End User Outlook**

- Hospitals
- Blood Banks
- Ambulatory Surgical Centers
- Home Care Settings

### **Blood Transfusion Device Market Application Outlook**

- Surgical Procedures
- Trauma Cases
- Cancer Treatment
- Plasma Exchange

### **Blood Transfusion Device Market Component Outlook**

- Blood Bags
- Blood Filters
- Infusion Sets

### **Blood Transfusion Device Market Regional Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### 监管合规与标准

监管合规在塑造输血设备市场中发挥着至关重要的作用。卫生当局施加的严格法规确保输血设备符合安全和有效性标准。遵守这些法规不仅增强了患者安全性，还在医疗服务提供者和患者之间建立了信任。市场受到对符合这些法规的设备需求的影响，这可能导致制造商的运营成本增加。然而，成功应对这些监管环境的公司可能会获得竞争优势，因为他们的产品更有可能在各种医疗环境中被接受。因此，输血设备市场受到不断变化的监管环境的显著影响，该环境持续优先考虑患者安全和质量保证。

### 提高对献血的认识

血液输送设备市场也受益于公众对献血重要性认识的提高。旨在教育公众献血需求的活动导致自愿献血数量的增加。这种提高的意识不仅增加了血液产品的可用性，还推动了对高效血液输送设备的需求。随着越来越多的人参与献血活动，医疗机构被迫增强其输血能力。因此，血液输送设备市场可能会看到增长，因为制造商会对增加的血液供应做出反应，提供确保安全有效输血的先进设备。

### 输血设备的技术进步

血液输送设备市场正因快速的技术进步而经历显著的转变。自动化血液采集系统和先进的血液筛查技术等创新正在提高输血的效率和安全性。例如，人工智能在血液管理系统中的整合正在简化操作，减少人为错误，并改善患者的治疗结果。此外，预计市场在未来几年将以约6.5%的复合年增长率增长，这一增长受到这些技术改进的推动。随着医院和血库越来越多地采用这些先进设备，血液输送设备市场可能会见证显著增长，反映出对改善医疗服务的持续承诺。

### 对血液制品的需求增加

血液产品需求的上升是血液输血设备市场的主要驱动力。老龄化人口、慢性疾病的增加以及手术程序数量的增长等因素都促成了这种需求。根据最近的估计，血液输血的需求预计每年将上升约5%，这就需要开发更高效的血液输血设备。这一趋势促使制造商创新并增强其产品供应，以满足医疗机构日益增长的需求。因此，血液输血设备市场有望扩张，企业专注于开发能够处理更大血量并提高输血安全性的设备。

### 新兴市场与医疗基础设施发展

新兴市场在输血设备市场中变得越来越重要。随着这些地区医疗基础设施的发展，对现代输血设备的需求日益增长。对医疗设施的投资和血库的建立正在推动对先进输血技术的需求。此外，随着这些市场的扩展，当地制造商与国际公司的合作潜力也在增加，这将导致针对特定区域需求推出创新产品。这一趋势表明，输血设备市场将继续发展，新兴市场在塑造其未来方面将发挥关键作用。

## Future Outlook

血液输送设备市场预计将在2024年至2035年间以4.05%的年均增长率增长，推动因素包括技术进步、对血液产品的需求增加以及医疗基础设施的改善。

**New opportunities:**

- 为紧急服务开发便携式输血设备。 在血液管理中集成人工智能进行预测分析。 扩展远程医疗解决方案以进行远程输血监测。

到2035年，市场预计将实现强劲增长，主要受创新和战略投资的推动。

## Segment Insights

### 按产品类型：自动输血设备（最大）与半自动输血设备（增长最快）

在输血设备市场中，自动输血设备占据了最大的市场份额，这归因于其高效性和在医院中的日益普及。这些设备在输血程序中提供了精确性，从而增强了患者安全性，因此吸引了关注优质护理的医疗服务提供者。半自动输血设备在市场中也占有重要地位，由于其经济实惠和易于使用，特别是在较小的医疗环境和紧急情况下，逐渐受到关注。增长趋势表明，自动和半自动设备都在向技术进步转变。手术程序和创伤护理中对输血的需求不断增加，推动了对可靠输血设备的需求。此外，慢性疾病的日益普遍和老龄化人口也促进了这一细分市场的扩展，半自动设备在各种医疗机构中逐渐成为首选。

自动（主导）与半自动（新兴）

自动输血设备因其高精度、高效率和安全特性而受到认可，使其成为大型医院和外科中心的主流选择。它们配备了先进的技术，自动化输血过程，减少人为错误并简化工作流程。相比之下，半自动输血设备作为一种新兴替代方案，特别适用于成本限制显著的小型环境。这些设备在性能和经济性之间取得平衡，满足更广泛的医疗设施需求。用户在使用半自动设备时体验到更大的灵活性和可用性，使其适合各种应用，尤其是在紧急和农村医疗环境中。随着医疗行业的发展，这两个领域都具备增长潜力。

### 按最终用户：医院（最大）与血库（增长最快）

在输血设备市场中，医院占据了终端用户的最大份额，这主要是由于它们在各种医疗程序中对输血的广泛需求。这些机构由于能够进行复杂的手术和处理创伤病例，因此占据了输血设备销售的显著比例。相比之下，血液银行虽然市场份额较小，但正迅速成为增长最快的细分市场，这得益于确保血液安全的不断努力以及各种献血活动的开展。

医院：（主导）与血库（新兴）

医院在输血设备市场中占据主导地位，因为它们需要广泛的设备来应对常规和紧急程序。它们的综合设施和对大量患者群体的接触使其在这一强势地位上得以巩固。相反，血液银行作为一个重要的细分市场正在崛起，专注于血液的收集、检测和储存。它们的增长得益于血液保存技术的创新以及对血液捐献重要性的提高认识。这一转变表明血液管理的多样化，不仅满足了即时需求，还关注血液供应的长期可持续性。

### 按应用：外科手术（最大）与创伤案例（增长最快）

在输血设备市场中，外科手术占据了最大的份额，这主要是由于选择性和紧急手术数量的增加。由于手术过程中对血液成分的迫切需求，这一细分市场通常被优先考虑，从而确保患者安全和提高生存率。创伤病例虽然是一个较小的细分市场，但由于事故和需要紧急输血的事件数量上升，需求迅速增加。

外科手术（主导）与创伤病例（新兴）

外科手术在输血设备市场中占据主导地位，始终是血液利用的主要领域，因为它在各种外科干预中具有关键性。该细分市场的特点是对即时和安全输血的依赖，使得在手术过程中能够有效管理患者。相反，创伤病例作为一种新兴应用，随着事故导致的创伤性伤害的增加，正在迅速获得关注。该细分市场在针对紧急护理的输血技术方面看到显著创新，展示了行业在应对紧急医疗需求方面的适应能力。

### 按组件：血袋（最大）与输液器（增长最快）

在输血设备市场中，组件细分市场显示出血袋、血液过滤器和输液器之间市场份额的多样分布。血袋仍然是该细分市场中最大的部分，这主要归功于它们在血液收集和储存中的重要作用。由于其安全特性和有效保持血液质量的能力，血袋受到青睐。相比之下，虽然血液过滤器和输液器也有显著贡献，但它们的市场份额较小，影响着该细分市场的整体动态。组件细分市场的增长趋势主要受到对安全有效的输血过程日益增长的需求驱动。输血依赖性疾病的发病率上升以及血液过滤技术的进步正在改变输液器的使用方式，使其成为该领域增长最快的产品。此外，旨在提高血袋效率和便利性的创新增强了其在市场上的持续主导地位。

血袋（主导）与输液器（新兴）

血袋在输血设备市场中至关重要，因为它们确保了血液的安全收集和保存。它们的设计重点在于最小化污染风险和最大化保质期，这使它们在该领域中占据主导地位。随着医院和血库继续优先考虑安全和质量，血袋因其先进的功能，如集成安全机制，越来越突出。另一方面，输液器代表了一个新兴的市场细分，受到技术创新和可用性增强的推动。这些设备因其能够确保输血过程中的安全输送和血流调节而变得至关重要。随着医疗服务提供者优先考虑有效的血液管理，这两个组件在市场中巩固了各自的独特角色。

## Regional Market Share Analysis

### 北美：创新的市场领导者

北美是血液输送设备最大的市场，约占全球市场份额的45%。该地区的增长受到先进医疗基础设施、血液疾病的日益普遍以及确保安全和有效性的严格监管框架的推动。对创新输血技术的需求进一步受到日益增强的意识和政府倡导的血液捐献及输血安全的推动。美国是该地区的领先国家，主要企业如海门尼克斯公司和百特国际公司在其中做出了重要贡献。竞争格局的特点是主要公司之间持续的创新和战略合作。加拿大也发挥着重要作用，越来越关注提升血液输送实践和技术，得到了威斯康星州血液中心等组织的支持。

### 欧洲：具有增长潜力的新兴市场

欧洲在血液输送设备市场上正经历显著增长，约占全球市场份额的30%。该地区受益于强大的医疗系统、对医疗技术的不断投资以及越来越多需要输血的外科手术。监管机构也在加强指导方针，以提高血液安全性，这是该地区市场扩展的关键驱动力。主要国家包括德国、法国和英国，主要企业如费森尤斯卡比公司和格里福尔斯公司积极参与其中。竞争格局的特点是公司之间的创新和合作，以开发先进的输血设备。欧洲市场还强调研究和开发，确保新技术满足医疗服务提供者和患者不断变化的需求。

### 亚太地区：快速增长的市场动态

亚太地区正在成为血液输送设备市场的重要参与者，约占全球市场份额的20%。该地区的增长受到医疗支出的增加、人口的上升以及慢性疾病的日益普遍的推动，这些疾病需要输血。此外，旨在改善医疗基础设施和提高血液捐献意识的政府倡议正在推动市场需求。中国和印度等国在这一增长中处于前沿，医疗设施的激增和对医疗技术的投资不断增加。竞争格局中既有本地企业也有国际企业，包括泰尔茂公司和美敦力公司，他们专注于扩大产品供应和增强分销网络，以满足对血液输送设备日益增长的需求。

### 中东和非洲：面临挑战的新兴市场

中东和非洲地区在血液输送设备市场上逐渐发展，约占全球市场份额的5%。增长受到医疗投资的增加、对血液捐献的意识提高以及对改善医疗服务的需求的推动。然而，监管挑战和对先进医疗技术的有限获取对该地区市场扩展构成了重大障碍。南非和阿联酋等国在市场中处于领先地位，努力提升血液输送实践和安全标准。竞争格局正在演变，本地和国际公司都在努力建立市场存在。主要参与者专注于合作伙伴关系和合作，以应对监管挑战并改善对基本血液输送设备的获取。

## Competitive Benchmarking

血液输送设备市场的特点是动态的竞争格局，受到技术进步、对血液产品需求的增加以及对患者安全日益重视的驱动。主要参与者如日本的Terumo Corporation、德国的Fresenius Kabi AG和西班牙的Grifols S.A.在战略上定位以利用创新并扩大其市场存在。Terumo Corporation专注于通过持续的研究和开发来增强其产品组合，而Fresenius Kabi AG则强调战略合作伙伴关系以增强其供应链能力。Grifols S.A.积极追求并购，以提高其运营效率和市场覆盖率。这些策略共同促成了一个日益以技术创新和战略合作为中心的竞争环境。

血液输送设备市场的关键商业策略包括本地化生产和优化供应链，以增强对区域需求的响应。市场结构似乎适度分散，几家主要参与者对各个细分市场施加影响。这种分散性使得小型参与者能够蓬勃发展，而大型公司则利用其规模来优化生产和分销。这些主要参与者的集体影响塑造了市场动态，促进了一个以创新和运营效率为重的环境。

2025年8月，Haemonetics Corporation（美国）宣布推出其新的血液管理软件，旨在简化输血过程并改善患者结果。这一战略举措强调了公司将数字解决方案整合到其产品中的承诺，可能增强其在一个日益以技术驱动的市场中的竞争优势。此类软件的推出不仅可能提高运营效率，还可能与医疗保健中日益增长的数据驱动决策趋势相一致。

2025年9月，Baxter International Inc.（美国）通过投资新设施扩大了其生产能力，专门用于血液输送设备的生产。这项投资反映了Baxter本地化生产和减少交货时间的战略，从而增强其供应链的韧性。这一举措可能使Baxter在竞争中处于有利地位，因为它寻求更有效地满足各个地区对血液产品日益增长的需求。

2025年7月，Grifols S.A.（西班牙）完成了对一家专注于血浆疗法的小型生物技术公司的收购。这项收购表明Grifols的战略是多样化其产品组合并加强其在血液输送市场的地位。通过将创新疗法整合到其产品组合中，Grifols可能增强其竞争差异化，并更灵活地应对不断变化的市场需求。

截至2025年10月，血液输送设备市场的当前竞争趋势越来越多地由数字化、可持续性和人工智能的整合所定义。主要参与者之间的战略联盟正在塑造市场格局，促进创新并提高运营效率。展望未来，竞争差异化可能会从传统的基于价格的竞争转向对技术进步、创新解决方案和可靠供应链的关注。这一转变表明，公司需要优先考虑研究和开发以及战略合作伙伴关系，以在一个不断发展的市场中保持竞争优势。

## Recent News & Developments

- **2024年第二季度：EryPharm宣布在大规模生产培养红细胞方面取得重大技术突破，以开发替代输血来源** EryPharm是一家生物技术初创公司，宣布在大规模生产培养红细胞方面取得了显著进展，旨在为输血提供替代来源，并改善多次输血患者的生活质量，这些患者患有遗传性或获得性红细胞疾病。[3]

此外，百特国际推出了旨在改善血液保存和储存的新设备，这一举措反映了医疗行业日益增长的需求。这些公司的市场估值稳步上升，为输血设备市场的乐观增长前景做出了贡献，因为利益相关者正在响应全球对安全输血服务日益增长的需求，这一需求受到持续医疗挑战的影响。

## Report Scope

| 2024年市场规模 | 4.698（十亿美元） |
| --- | --- |
| 2025年市场规模 | 4.888（十亿美元） |
| 2035年市场规模 | 7.272（十亿美元） |
| 复合年增长率（CAGR） | 4.05%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 先进自动化和数字解决方案的整合提高了输血设备市场的效率。 |
| 主要市场动态 | 技术进步和监管变化推动了输血设备市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，血液输送设备市场的预计市场估值是多少？**
A: 到2035年，输血设备市场预计将达到727.2亿美元的估值。

**Q: 2024年血液输送设备市场的市场估值是多少？**
A: 2024年，输血设备市场的价值为46.98亿美元。

**Q: 在2025年至2035年的预测期内，血液输送设备市场的预期CAGR是多少？**
A: 在2025年至2035年的预测期内，输血设备市场的预期CAGR为4.05%。

**Q: 到2035年，预计哪个产品类型细分市场的估值最高？**
A: 到2035年，手动输血设备的预期估值将达到30亿美元。

**Q: 2024年和2035年自动输血设备的估值如何比较？**
A: 自动输血设备从2024年的15亿美元增加到2035年预计的24亿美元。

**Q: 到2035年，血库作为最终用户的预期市场规模是多少？**
A: 到2035年，血库作为最终用户的市场规模预计将达到18亿美元。

**Q: 到2035年，预计哪个应用领域的增长幅度最大？**
A: 癌症治疗预计将显著增长，到2035年预计达到20亿美元。

**Q: 到2035年，输液器的预期估值是多少？**
A: 预计到2035年，输液器的估值将达到32亿美元。

**Q: 血液输送设备市场的关键参与者是谁？**
A: 市场上的主要参与者包括Terumo Corporation、Fresenius Kabi AG、Grifols S.A.和Haemonetics Corporation。

**Q: 在血液输送设备市场中，家庭护理环境的预期增长趋势是什么？**
A: 家庭护理环境预计将从2024年的8.19亿美元增长到2035年的12.72亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/blood-transfusion-device-market-37044*